March 2, 2009 - The American Society for Radiation Oncology (ASTRO) applauds President Obama’s healthcare reform plan to double funding for cancer research and close loopholes that are weakening the Medicare program.

ASTRO believes that the integrity of the Medicare program and quality patient care is being compromised by loopholes in the physician self-referral law - or Stark Law. One particular loophole, called the in-office ancillary exception (IOAE), has become the "loophole that has swallowed the rule".

"There is evidence that some physicians are using the ancillary exception to drop 'turn-key' radiation therapy services into group practices to maximize profit. We are afraid these arrangements compromise the quality of care, limit access, constrain patient choice from the full range of treatment options and result in overutilization of certain treatments," said Laura I. Thevenot, ASTRO's CEO. "ASTRO is committed to working with President Obama and Congress to prevent profit-motivated self-referrals and preserve the independent judgment and choice that patients deserve in making life and death decisions."

ASTRO is asking President Obama and Congress to close the IOAE loophole and responsibly address abuses of the self-referral law. By taking these actions, it believes budgetary savings may result that help advance the President's healthcare priorities. For instance, savings could help increase funding for cancer research or expand coverage, both of which are critical to keep people healthy, save lives and stimulate the economy.

ASTRO strongly supports comprehensive healthcare reform and looks forward to working with the President and Congress to expand coverage of the uninsured, double funding for life-saving cancer research, and strengthen Medicare by fixing its physician payment system and protecting the program's integrity.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.

For more information: www.astro.org


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
Subscribe Now